Skip to main content

Site notifications

Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.

Sub menu

News and events
Contact us
About us

Search

Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

You are here

Home
Resources and guidance
Sponsors

Generic Partners Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (66)
Prescription medicine registration (21)
Australian public assessment report (AusPar) (1)

Date

2022 (38)
2021 (6)
2020 (5)
2019 (22)
2018 (14)
2017 (2)
2016 (1)

Search

Sponsor content

88 result(s) found, displaying 81 to 88

OLMESARTAN GxP, OLMESARTAN GPPL, OLMES, OLMESART (Generic Partners Pty Ltd)

23 January 2018

Prescription medicine registration

Active ingredients: olmesartan medoxomil.
OLMESARTAN MEDOXOMIL HCTZ GP, OLMESARTAN HCT GPPL, OLMESART HCT GXP, OLMESART HCT (Generic Partners Pty Ltd)

23 January 2018

Prescription medicine registration

Active ingredients: olmesartan medoxomil & hydrochlorothiazide.
AZALINE, AZIGILINE, ASAGILINE, RASAZILECT, RASAGILINE MYLAN, RASAGILINE GPPL, RASAGILINE GXP (Generic Partners Pty Ltd)

11 January 2018

Prescription medicine registration

Active ingredients: rasagiline mesilate.
LENCADOPA, LEVOCARBAMET, LEVODOPA/CARBIDOPA GPPL, LEVOCARBAMET, LEVODOPA/CARBIDOPA GXP, APO-LEVODOPA/CARBIDOPA, LEVODOPA/CARBIDOPA GENPAR (Generic Partners Pty Ltd)

5 January 2018

Prescription medicine registration

Active ingredients: levodopa / carbidopa.
IVABRADINE GPPL, IVABRADINE GXP, COBADINE, APO-IVABRADINE, CORALIVAN, CIVABRADINE, IVABRADINE NHPL (Generic Partners Pty Ltd)

2 January 2018

Prescription medicine registration

Active ingredients: ivabradine (as hydrochloride).
DEOTINE 60 duloxetine (as hydrochloride) 60 mg enteric capsule blister pack Cancelled under s30(1)(c)

30 June 2017

Cancellation by sponsor

Requested by Generic Partners Pty Ltd
DEOTINE 30 duloxetine (as hydrochloride) 30 mg enteric capsule blister pack Cancelled under s30(1)(c)

30 June 2017

Cancellation by sponsor

Requested by Generic Partners Pty Ltd
AusPAR: Gliclazide

22 July 2016

Australian public assessment report (AusPar)

Australian Public Assessment Report for Gliclazide

Pages

First page
Previous page
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Current page 9

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.

© Commonwealth of Australia